Lipocine
LPCN
LPCN
32 hedge funds and large institutions have $12.8M invested in Lipocine in 2021 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 4 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
24% less funds holding
Funds holding: 42 → 32 (-10)
71% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 14
Holders
32
Holding in Top 10
–
Calls
$1.99M
Puts
$301K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$409K | |
| 3 | +$323K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$219K |
| 5 |
Mercer Global Advisors
Denver,
Colorado
|
+$115K |
Top Sellers
| 1 | -$289K | |
| 2 | -$217K | |
| 3 | -$132K | |
| 4 |
Squarepoint
New York
|
-$127K |
| 5 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$83K |